Results 101 to 110 of about 4,839,288 (277)
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou +16 more
wiley +1 more source
Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study
ABSTRACT Objective Autoimmune autonomic ganglionopathy (AAG) is a rare but potentially treatable cause of severe autonomic failure. Evidence guiding long‐term immunotherapy, treatment sequencing, and residual autonomic impairment is limited. We evaluated long‐term treatment response, residual autonomic dysfunction, and relapse patterns in patients with
Giacomo Chiaro +6 more
wiley +1 more source
Managing behaviour in functional neurological disorders
Functional neurological disorders that occur in the context of neurological conditions present considerable clinical challenges. Following a historical review of hysterical or functional conditions, the contemporary neuropsychological basis for ...
Methley, Abigail +2 more
core +1 more source
MOGAD Is the Most Common Cause of Isolated Optic Neuritis in Children
ABSTRACT Objectives The study aimed to characterize the clinical features, etiologies, and outcomes of isolated, first‐time pediatric ON in the post‐MOG‐IgG era. Methods This was a single‐center retrospective cohort study at Texas Children's Hospital of patients diagnosed with first‐time ON between 2018–2024, with follow‐up data collected through 2025.
Chaitanya Aduru +13 more
wiley +1 more source
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw +5 more
wiley +1 more source
Major depressive disorder (MDD) is one of the most frequent psychiatric illnesses, leading to reduced quality of life, ability to work and sociability, thus ranking among the major causes of disability and morbidity worldwide.
Hélène Party +14 more
doaj +1 more source
Stroke-Mimicking conditions: functional neurological disorders, diagnostic challenges, and differentiation. [PDF]
Stroke mimics is a heterogeneous group of disorders that present with stroke-like symptoms but are not associated with cerebrovascular damage. The prevalence of stroke mimics varies according to different sources: 4.1%-12.3% in stroke treatment centers ...
Liaudinskaitė, Viltė,
core
Functional neurological disorders: can yoga improve wellbeing?
Background: Functional neurological disorders are complex conditions characterised by involuntary motor and sensory symptoms, in addition to psychological disorders such as anxiety and brain fog. Treatments aim to
James Povey +4 more
core +1 more source
ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit +11 more
wiley +1 more source
Field switching of microfabricated metamagnetic FeRh MRI contrast agents
In a step towards generating switchable MRI cellular labels, we demonstrate in-situ field switching of micron scale metamagnetic Iron-Rhodium (FeRh) thin film particles.
Stephen Dodd +9 more
doaj +1 more source

